Clinical trial

A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

NCT00134693

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Prednisolone Normalized identity: prednisoloneView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention SB-681323 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-06-21

PhasePHASE2

Conditions

Arthritis, Rheumatoidunresolved

Interventions

PrednisoloneDRUG · verified · RxNorm: prednisolone

SB-681323DRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

BerlinGermany4 MoscowRussia1 MontpellierFrance1 YaroslavlRussia1 SheffieldUnited Kingdom1 OxfordUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00134693 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.